Status:
TERMINATED
Impact of CTO PCI (Chronic Total Occlusion Percutaneous Intervention) on Regular Physical Activity
Lead Sponsor:
Minneapolis Heart Institute Foundation
Conditions:
Chronic Total Occlusion
Occlusion
Eligibility:
All Genders
18+ years
Brief Summary
Heart disease is a leading cause of death in the US. . Heart blood vessel chronic total occlusions are 100% blockages of the heart vessels. These patients often suffer from chest pain, shortness of br...
Detailed Description
The investigators will compare the daily steps before and after the procedure to understand if the patients are more active. In addition to tracking daily steps, The investigators will track calorie e...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Willing and able to provide informed consent
- Patients referred for clinically indicated CTO-PCI
- Access to smart phone (Apple or Android platform)
- Willing and able to wear a smart watch
- Clinically stable and able to walk/ exercise independently
Exclusion
- Inability to exercise due to non-cardiac problems (e.g., orthopedic restrictions, amputation, musculoskeletal/neurological disease affecting mobility etc.-as determined by investigator discretion)
- Plan for major surgical procedure (other than CTO PCI) which would limit exercise capability
- Any other criteria that in the opinion of the investigator would preclude patient participation in the study and/or impact exercise capability.
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT05440084
Start Date
September 1 2022
End Date
September 1 2024
Last Update
January 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, United States, 55407